Keystone Financial Group (Kentucky)’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$537K Sell
3,863
-519
-12% -$72.7K 0.04% 287
2025
Q4
$538K Sell
4,382
-50
-1% -$6.08K 0.04% 247
2025
Q3
$494K Buy
4,432
+990
+29% +$113K 0.04% 238
2025
Q2
$382K Buy
3,442
+813
+31% +$86.5K 0.03% 267
2025
Q1
$295K Buy
+2,629
New +$271K 0.03% 296
2022
Q1
Sell
-3,182
Closed -$231K 304
2021
Q4
$231K Sell
3,182
-700
-18% -$48.2K 0.04% 274
2021
Q3
$271K Sell
3,882
-300
-7% -$21.1K 0.05% 241
2021
Q2
$288K Hold
4,182
0.05% 233
2021
Q1
$270K Sell
4,182
-35
-0.8% -$2.26K 0.05% 234
2020
Q4
$246K Buy
4,217
+160
+4% +$9.65K 0.05% 226
2020
Q3
$256K Sell
4,057
-594
-13% -$41.2K 0.06% 196
2020
Q2
$358K Sell
4,651
-1,168
-20% -$89.5K 0.1% 155
2020
Q1
$435K Buy
5,819
+2,096
+56% +$145K 0.14% 120
2019
Q4
$242K Sell
3,723
-196
-5% -$12.8K 0.07% 211
2019
Q3
$248K Buy
3,919
+363
+10% +$23.7K 0.08% 197
2019
Q2
$240K Sell
3,556
-90
-2% -$5.92K 0.08% 195
2019
Q1
$237K Buy
+3,646
New +$242K 0.08% 185
2018
Q4
Sell
-2,867
Closed -$224K 186
2018
Q3
$224K Buy
+2,867
New +$217K 0.09% 173
2018
Q2
Sell
-2,913
Closed -$213K 173
2018
Q1
$213K Sell
2,913
-298
-9% -$23.7K 0.12% 144
2017
Q4
$239K Buy
+3,211
New +$244K 0.15% 107

Other funds holding GILD

Keystone Financial Group (Kentucky)'s GILD Position: Q1 2026 in Review

Keystone Financial Group (Kentucky) reduced its Gilead Sciences (GILD) stake by 12% in Q1 2026, selling an estimated $72.7K and leaving 3,863 shares worth $537K. The position accounts for 0.04% of the portfolio, ranked #287.

Keystone Financial Group (Kentucky) first reported a position in GILD in Q4 2017 and has held it in 20 quarters since. The position peaked at $538K in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Keystone Financial Group (Kentucky) held 3,863 shares of Gilead Sciences worth $537K as of Q1 2026.
  • Keystone Financial Group (Kentucky) sold 519 Gilead Sciences shares in Q1 2026, an estimated $72.7K.
  • Gilead Sciences made up 0.04% of Keystone Financial Group (Kentucky)'s portfolio in Q1 2026, its #287 holding.
  • Keystone Financial Group (Kentucky) first reported a position in Gilead Sciences in Q4 2017 and has held it in 20 quarters since.
  • Keystone Financial Group (Kentucky)'s Gilead Sciences position peaked at $538K in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Keystone Financial Group (Kentucky)'s 13F filing for Q1 2026, filed 13 May 2026.